The enhanced anti-tumor effects observed with M-HIFU, including increased OLFM4-specific cytotoxic lymphocyte activity and a higher frequency of IFN-γ-producing splenocytes, indicate its potential as a more effective approach for targeting OLFM4-expressing tumors. The gene discussed is IFNG; the disease is neoplasm.